Kristoffer Sand

发表

Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients

Ø. Bruserud, A. Kittang, B. Mannsăker, 2013, Oncoimmunology.

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Ø. Bruserud, G. Mufti, T. Seidl, 2015, Oncoimmunology.

Cardiopulmonary resuscitation retention training for hospital nurses by a self-learner skill station or the traditional instructor led course: A randomised controlled trial

T. Hole, D. A. L. Hoff, Kristoffer Sand, 2021, Resuscitation plus.

The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes

Ø. Bruserud, A. Brenner, A. Kittang, 2016, International journal of molecular sciences.

Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes

Ø. Bruserud, J. Theorell, Y. Bryceson, 2016, Cancer Immunology, Immunotherapy.

The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity

Ø. Bruserud, J. Lord, B. Gjertsen, 2010, Toxins.

Targeting Immune Signaling Pathways in Clonal Hematopoiesis.

Patrycja Mensah-Glanowska, A. Kittang, Kristoffer Sand, 2019, Current medicinal chemistry.

The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications.

Ø. Bruserud, H. Reikvam, A. Kittang, 2010, Current topics in microbiology and immunology.

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

Ø. Bruserud, G. Mufti, T. Seidl, 2015, Oncoimmunology.